Related Experiment Videos
[Heparin in acute cerebral ischemia].
1Servicio de Neurología, Hospital Clínic, Barcelona. chamorro@medicina.ub.es
Neurologia (Barcelona, Spain)
|June 24, 1999
Summary
Non-fractionated heparin shows limited efficacy and increased complications in neurovascular diseases. Further research is needed to explore its potential anti-inflammatory effects for acute ischemic stroke treatment.
Area of Science:
- Neurology
- Pharmacology
Context:
- Non-fractionated heparin is a standard treatment for neurovascular diseases due to its antithrombolytic properties.
- Recent clinical studies have yielded discouraging results regarding its efficacy and safety profile.
Purpose:
- To critically analyze the reasons behind the poor outcomes of non-fractionated heparin in neurovascular diseases.
- To highlight recent advancements in understanding heparin's mechanism of action, including its anti-inflammatory potential.
Summary:
- The article reviews the ineffectiveness and complications associated with non-fractionated heparin in neurovascular conditions.
- It emphasizes the need to investigate heparin's anti-inflammatory role and the experimental conditions required for its expression.
Impact:
- Suggests a re-evaluation of non-fractionated heparin's therapeutic role in acute ischemic stroke.
- Underscores the importance of considering heparin's anti-inflammatory properties in future research and clinical applications.